06 Nov CRISPR/Cas9 screening to identify genetic vulnerabilities in doxorubicin-resistant osteosarcoma

Posted at 15:28h in DRUG TOLERANCE by

ID: 03286

Authors: Murillo , Dzohara (1,2); Rey, Verónica (1,2,3); Gallego, Borja (1,2); Huergo, Carmen (1,2); Tornín, Juan (1); Sánchez, Natalia (4); Varela, Ignacio (4); Álvarez-Fernandez, Mónica (1,2); Sweet-Cordero, Alejandro (5); Rodríguez, René (1,2,3)

Topic: DRUG TOLERANCE